Fast track drugs fears for NHS budget

Unregulated pharmaceuticals may be allowed to inflate the NHS drugs bill for little benefit to patients according to some people in the medical profession.

Unregulated pharmaceuticals may be allowed to inflate the NHS drugs bill for little benefit to patients according to independent health policy analyst Roy Lilley.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here